References
- Walker JJ. Pre-eclampsia. Lancet 2000;356:1260–5
- Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008;199:36.e1–e5
- Spencer K, Cowans NJ, Chefetz I, et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007;29:128–34
- Di Lorenzo G, Ceccarello M, Cecotti V, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012;33:495–501
- Behringer RR. The in vivo roles of müllerian-inhibiting substance. Curr Topics Develop Biol 1994;29:171–87
- Kevenaar ME, Meerasahib MF, Kramer P, et al. Serum anti-müllerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006;147:3228–34
- Köninger A, Kauth A, Schmidt B, et al. Anti-mullerian-hormone levels during pregnancy and postpartum. Reprod Biol Endocrinol 2013;11:60(1–9)
- Celik Y. Biostatistics, principles of research. Diyarbakir: Dicle University Press; 2007
- Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
- World Health Organization. The world health report: 2005: make every mother and child count. Geneva: WHO; 2005
- Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension fetal medicine units. N Engl J Med 1998;339:667–71
- Inversetti A, Smid M, Candiani M, et al. Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease. Expert Opin Biol Ther 2014;14:1161–73
- Luque A, Farwati A, Crovetto F, et al. Usefulness of circulating microRNAs for the prediction of early preeclampsia at first trimester of pregnancy. Sci Rep 2014;4:4882(1–8)
- Poon LCY, Kametas NA, Maiz N, et al. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812–18
- Myers JE, Kenny LC, McCowan LM, et al.; SCOPE consortium. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG. 2013;120:1215–23
- Myers JE, Kenny LC, McCowan LM, et al.; SCOPE consortium. Authors' reply: angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG 2014;121:507
- Weenen C, Laven JS, von Bergh AR, et al. Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77–83
- Visser JA, Themmen AP. Anti-mullerian hormone and folliculogenesis. Mol Cell Endocrinol 2005;234:81–6
- Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001;142:4891–9
- Fanchin R, Maria Schonauer L, Righini C, et al. Serum AMH is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323–7
- Cui Y, Shi Y, Cui L, et al. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome. Fertil Steril 2014;101:230–36
- Yarde F, Maas AH, Franx A, et al. Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging. J Clin Endocrinol Metab 2014;99:579–86
- Shand AW, Whitton K, Pasfield A, et al. Evaluation of anti-Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol 2014;54:244–9
- Li HW, Ng EH, Wong BP, et al. Correlation between three assay systems for anti-Müllerian hormone (AMH) determination. J Assist Reprod Genet 2012;29:1443–6